Merck & Co., Inc. — Director's Dealing 2014

Feb 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-02-24

Reporting Person: Schechter Adam H (EVP & Pres-Global Human Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-24	Common Stock	A	22287.0000	$56.1800	Acquired	22287.0000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70507.9747	Indirect

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 03/31/2011. Performance shares were paid out at 86 percent of target awards.

F2: Holdings include shares acquired in dividend reinvestment transactions.